Anti-Hypertensives Flashcards
1st line drugs
A: ACE inhibitor
B: beta blockers
C: calcium channel blockers
D: diuretics
2nd line drugs
Hydralazine
Mineralocorticoid receptor antagonists
Alpha blockers (Prazosin etc)
Examples of ACE inhibitors
Captopril
Enalapril
Lisinopril
ACE inhibitors ADR
Severe hypotension
Acute renal failure
Hyperkalemia
Angioedema
Dry cough (bradykinin, substance P)
Contraindicated in pregnancy
ACE Inhibitors Uses
Hypertension
Cardiac failure
After MI
What does Ag II Type 1 (AT1) blockers block
Block interaction between Ag II & its receptor (AT1)
Ang II Type 1 blockers ADR
Dry cough
Contraindicated in pregnancy
Which 2 drugs should not be used together
ACE inhibitors & AT1 blockers
Can worsen side effects & lower efficacy
Examples of AT1 receptor blocker
Losartan
Valsartan
Examples of beta blockers
Non-selective: Carvedilol, Propranolol
Cardioselective: Bisoprolol, Metoprolol XL, Atenolol
Mixed (3rd gen): Nebivolol
Beta blockers ADR
Bradycardia
Clinical depression
Hypotension
Asthma
Bronchoconstriction
AV nodal block
Beta blockers uses
Hypertension
Cardiac Failure
Following MI
Abnormal heart rhythm
Anxiety disorders
Which diuretics to use to lower BP
Thiazides
Calcium channel blockers names
Non-DHP: Verapamil, Diltiazem
DHP: Nifedipine
Difference between DHP vs Non-DHP CCB
DHP - greater effect on cardiac depression
Non-DHP - greater effect on vasodilation
Both equally as effective at reducing cardiac contractility
Non-DHP calcium channel blocker MOA (Verapamil, Diltiazem)
Decrease SA/AV conduction, decrease supraventricular & re-entry tachycardia
Uses of non-DHP calcium channel blocker (Verapamil, Diltiazem)
Anti-arrhythmia
DHP calcium channel blocker MOA (Nifedipine, Amlodipine)
Decrease myocardial contractility: decrease oxygen requirement, decrease CO –> decrease BP
Decrease vascular smooth muscle tone –> decrease BP
DHP calcium channel blocker (Nifedipine, Amlodipine) ADR
Cardiac depression: bradycardia, AV block, heart failure
DHP calcium channel blocker (Nifedipine, Amlodipine) Uses
Anti-angina
Anti-hypertension
Prazosin MOA
Lower vessel tone (dilation), lower peripheral resistance, lower BP
Prazosin PK
Reach peak concentration in 2.5h
t/12: 7h
Extensively bound to plasma protein
M in liver
E in feces & bile
Prazosin ADR
(can use in patients with renal impairment)
Reflex tachycardia/palpitations, orthostatic hypotension
Depression, urinary frequency, flushing
Hydralazine MOA
Direct arteriole vasodilator
Inhibit IP3-induced calcium release from smooth muscle cells sarcoplasmic reticulum
Lower peripheral resistance, compensatory relase of NE/E, increase venous return & CO
Hydralazine PK
IV: onset 5-30min, duration 2-6h
Oral: onset 20-30min, duration 2-4h
Reach peak plasma concentration in 2.5h
t1/2: 7h
Hydralazine Uses
Oral: HFrEF
Essential hypertension (when 1st line medications unsuitable/inadequate)
IV: Acute onset, severe peripartum/post partum hypertension (>15min)
Hydralazine ADR
Baroreflex associated sympathetic activation: flushing, hypotension, tachycardia
Hydralazine-induced lupus syndrome (HILS): arthralgia, myalgia, serositis, fever
Contraindicated: coronary artery disease (stimulates sympathetic nervous system, increase CO & O2 demand, myocardial ischaemia)